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 Infants with congenital diaphragmatic hernia (CDH) 
operated on at 12 hours of age have poor prognosis. 
Development of severe hypoxemia due to hypoplastic lung 
and pulmonary vascular constriction is the major prognostic 
factor. Infants who show reasonable gas exchange at first but 
develop severe hypoxemia a few hours following surgery 
(honeymoon period) may have benefited from delayed 
radical surgery. During the waiting period, the patient 
should be kept on a minimal handling and stabilizing 
protocol. 
 In our institute, 24 CDH patients were treated from 1970 to 
1995. These patients were divided into two groups : group I 
(n = 11) was the first stage (1970~1984), group II (n = 13) 
was the second stage (1985~1995). The total survival rate of 
these two groups did not improve. However our experience 
with the last six cases using this stabilizing protocol between 
1989 and 1995 suggests that delayed repair surgery for CDH 
improved the survival rate. The survival rate changed from 
33.3% in group I to 44.4% in group II. We report our cases, 
including clinical status, surgical findings and treatments.
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Introduction 
 Congenital diaphragmatic hernia (CDH) has one of the 
worst prognoses of any disease, in spite of remarkable 
improvements in most outcomes of the major neonatal due 
to progress in perioperative management. The physiologi-
cal mechanisms of this disease have been clarified recently, 
and delayed operation has been chosen in some institutes. 
The present study was undertaken to compare the outcome 
of emergency operation with delayed operation for CDH in 
our department.
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Materials and Methods 
 From 1970 to 1995, 24 patients were referred to our 
institute for surgical treatment of CDH. We reviewed their 
charts for antenatal conditions, birth weights, gestational 
ages, symptoms, the presented time of the symptoms, 
preoperative conditions and management. The first 
antenatal diagnosed case was transferred to our depart-
ment in 1983. Until that time, CDH patients had always 
been operated on just after admission. However now we 
are treating the earlier cases of CDH, especially those 
expressed during the first 12 hours of life, according to the 
new protocol, in which the principle of management is 
delayed operation (Table 1). If the patients did not develop 
respiratory symptoms, such as tachypnea, mild to moder-
ate dyspnea, retractions or cyanosis, within the first 12 
hours after birth, early operations were performed. On the 
other hand, if symptoms developed within the first 12 
hours, we treated the patient according to the stabilizing 
protocol and planning of delayed operation. For this 
study, patients were divided into two groups : group I 
was treated before 1984, and group II was treated from 
1985 to 1996. In 1989, we started the new management 
using the stabilizing protocol for CDH patients who 
presented symptoms within the first 12 hours. 
Stabilizing Protocol 
 We treated patients in whom symptoms developed early 
according to the stabilizing protocol : (1) Minimum 
handling. (2) Sedation and muscle relaxant : At the 
induction, pancuronium 0.02-0.3 mg/kg and morphine 
chloride 0.05--0.2 mg/kg were injected in two shots, then 
maintenance doses of pancronium 0.03-0.1 mg/kg/hr and 
morphine chloride 0.1-0.2 mg/kg/hr were given. (3) 
Mechanical ventilation : either conventional ventilation 
(IMV) or high frequency oscillatory ventilation (HFO). 
At the start of HFO, parameters were set at FiO2 1.0, 
frequency 15Hz, mean airway pressure (MAP) 12 cm H2O 
and amplitude 20. (4) Gastrointestinal drainage using 8 Fr 
nasogastric sump tube. (5) Less water in the first 48 hours
of life, 40-60 ml/kg/day. (6) Control of blood pressure 
and urination with dopamine 3-10 u g/kg/min and 
dobtamine 3-10,u g/kg/min. (7) Monitoring of body 
temperature, electrocardiogram, blood pressure, urine 
volume, percutaneous gas pressure, and pulse oxy-meter 
(upper and lower extremities). (8) If persistent fetal 
circulation (PFC) occurred, at first we tried hyperventila-
tion, venous injection of sodium bicarbonate, increase of 
sedative drugs and posture change. (9) If the patent fetal 
circulation could not be controlled, we used lipo-PGE1 
(0.002--0.005u g/kg/min) and Imidalin (1-2 mg/kg/min; 
bolus injection and 0.25--2.0 mg/kg/min, continuous dose) 
starting with volume expander preparing for the decrease 
of blood pressure.
Results 
 A total of 24 patients were studied 11 in group I and 13 
in group II . The results are summarized in Table 1. In 
group I , the age at the time of diagnosis varied, and total 
survival rate was 72.7%. In group I[, the age at the time 
of diagnosis was lower than that of the former group : 
prenatal = 5, within the first 12 hours = 4, 12 to 24 hours 
= 1 and after 24 hours = 3 . Total survival rate was 61.5%, 
lower than that of group I. However, among the patients
who developed symptoms within the first 12 hours of life, 
the survival rate of group II (44.4 %) .was better than that 
of group I (33.3%). 
 Data on the eight patients who died are summarized in 
Table 2. In all these cases, symptoms appeared before 6 
hours, except for in one case (case 1). Two cases were right 
sided, and all defects were completely closed without any 
materials. Six patients needed preoperative respiratory 
support, which consisted of intratracheal intubation only 
in one patient, intermittent mechanical ventilation in four 
patients and high frequency osccillatory ventilation in one 
patient. Most of these patients died because of hypoplastic 
lung and postoperative induced PFC, but some of them 
could have survived if they had been treated by the delayed 
operation method. 
 The six cases that were treated by the stabilizing proto-
col and delayed operation are summarized in Table 3. Four 
of them were diagnosed by prenatal fetal ultrasonography. 
The stabilizing period was two to nine days. Five of these 
patients are alive and showing a good postoperative 
course. Unfortunately, ipsilateral pneumothorax occurred 
during the stabilizing period in one patient, who died 5 
hours after birth. In this case, the mean airway pressure 
was too high to maintain better oxygenation, and the 
hypoplastic lung was damaged.
Table 1. Prognosis of Congenital Diaphragmatic Hernia 
     Age st time 1970-1984 1985-1995 Total 
      of diagnosis alive dead(servival rate) alive dead(servival rate) alive dead(servival rate) 
     prenatal 0 1 ( 0 %) 4 1 ( 80 %) 4 2 (66.7%)
     <12 hrs 1 1 (50 %) 0 4 ( 0 %) 1 5 (16.7%) 
     12-24 hrs 1 1 ( 50 %) 1 0 (100 %) 2 1 (66.7%) 
    24hrss 6 0 (100%) 3 0 (100 %) 9 0 (100 %) 
                          8 3 (72.7%) 8 5 (61.5%) 8 3 (72.7%)
Table 2. Summary of Patients who Died of Congenital Diaphragmatic Hernia 
 Case Age BW Symptoms Preop. management Defect Postop. course Survival 
            (GA) (associated anomaly) (Organs) period 
  1 15 hrs 2,020 g cyanosis IMV (6 hrs) 5 x 4.5 cm IMV 
     M (36 w) dyspnea (St•Sp•L•G) sepsis •DIC 29 day 
  2 5 hrs 2,020 g cyanosis Oxygenation 3 x 4 cm : C IMV 
     M (37 w6d) (ARM) (St•Sp•L) colostomy 3 day 
  3 Pre.D. 2,860 g cyanosis intubation•O2 Rt, 3 x 4 cm IMV 
     F (36 w6d) abd. distension (Duodenal Atresia) (L•St) 4 hrs 
---------------- --------------- - - ---- - --- - ------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------
  4 4 hr 2,897 g cyanosis Oxygenation 4 x 5 cm IMV 
      M (37 w4d) retractive resp. (multiple hemangioma) (St•Sp•L•G) DIC-cardiac failure 83 days 
  5 at birth 1,680 g dyspnea IMV Rt, 3 x 3 cm IMV 
     M (38 w4d) (L•St) 18-trisomy 3 days 
  6 3 hrs 3,400 g dyspnea IMV 4 x 3 cm sirculatory disturbance 
     M (39 w) cyanosis (St•Sp•G•L) 3 hrs 
  7 Pre.D. 3,660 g cyanosis IMV 5 x4 cm progressive acidosis 
     M (41 w) (St•Sp•G) 9 hrs 
  8 at birth 2,740 g resp. arrest IMY-HFO NO contralateral pneumothorax 26 hrs 
     M (38 w) 
IMV : Intermittent mechanical ventilation, HFO : High frequency oscillatory ventilation, ARM Ano-rectal malformation 
Herniated organs ; St = stomach, Sp = spleen, L = liver, G - amall and/or large intestine 
Case 1-3: Goupe I, Case 4-8: Groupel
Table 3. Cases with delayed operation : Congenital Diaphragmatic Hernia 
 Case Sex Time or Dx Bw(g)/GA Delivery Apgar Stabilizing period Prognosis 
   1 d' GA20w2d 2,570 g/39w5d vaginal 6-'7 4 days alive 
   2 GA20wld 3,100 g/39w3d C/S 4-'7 7 days alive 
   3 d' GA27w5d 3,180 g/39w3d vaginal 3-'4 2 days alive 
   4 d' GA28w 3,180 g/41w3d C/S 6-'6 9 days alive 
   5 a' 15 hrs 3,340 g/40w vaginal 8-'9 3 days alive 
   6 - 2 hrs 2,648 g/41w vaginal 9-'10 5 days dead 
C/S : Caesarean section, Apgar Score (1 min.-'5 min.)
Discussion 
  In 1953, Gross') reported the first successful surgery of a 
case of CDH in which symptoms were expressed in the first 
24 hours. At that time the most important physiological 
problem related to CDH was thought to be herniated 
organs depressing the lung, and until 1979, an earlier 
surgery was considered the best treatment. In the 1980s, it 
was suspected that the prognostic factor was the 
hypoplastic lung. Consequently, Miyasaka et al'), proposed 
delayed operation for CDH, preventing PFC. They believed 
that emergency operation during the early stage was 
unwise because fetal circulation is shifting and unstable 
during this period. 
  Atkinson et a13), reported the results of a multi-center 
trial, in which symptoms were expressed in the first 12 
hours and needed intratracheal intubation. There was no 
difference between the emergency operation cases and the 
delayed operation cases, and they reported that delayed 
operation improved patient survival rate with or without 
extracorporeal membranous oxygenation (ECMO). 
 Patients with CDH that does not express any symptoms 
within 12 hours after birth generally have acceptable lung 
function and a survival rate close to 100% after operation. 
On the other hand, high-risk patients presenting respira-
tory distress within 12 hours after birth may have signifi-
cant pulmonary hypoplasia, and there is a high mortality 
rate among such patients. 
 Several new techniques have been used in the treatment 
of CDH during the last decade. HFO has been successfully 
used in neonates who have severe respiratory distress and 
pulmonary hypertension. ECMO has been used preopera-
tively, perioperatively, and postoperatively in high-risk 
patients when conventional treatment has failed. A 
significant increase in survival rate when using ECMO has 
been shown in several reports"""). An exception, however, 
are neonates with pulmonary hypoplasia caused by CDH or 
some other cause, in which HFO seems to be less suc-
cessful','). Nevertheless HFO as early intervention, rather 
than rescue therapy, may be advantageous, since this 
avoids iatrogenic trauma induced by conventional ventila-
tion. In our experience, one patient died during the stabiliz-
ing period because of iatrogenic barotrauma that led to 
contralateral pneumothorax. ECMO shoud be considered 
in case as such as this.
 Nitric oxide (NO) is normally synthesized in endothelial 
cells. As a potent vasodilator, it is a principal regulator of 
vascular tone. Inhaled NO acts as a selective vasodilator 
of the pulmonary vascular bed because it is rapidly me-
tabolized before it reaches the systemic circulation'). Its 
success rate may, however, be lower in CDH patients than 
in neonates in general. 
 The present investigation suggests that in our depart-
ment the use of preoperative stabilization with HFO and/ 
or conventional ventilation and delayed surgery improved 
the recovery rates of CDH patients whose symptoms were 
expressed in the first 12 hours. However, further investiga-
tion is needed to determine the clear parameters that can 
be used with blood gas data. Also, other methods, such as 
ECMO or NO inhalation, should be used in the more 
critical cases to improve the survival rate of the neonates 
with CDH in which symptoms are expressed within the 
first 12 hours.
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